Understanding the Complexity and Uniqueness of Phase I Trials
In clinical research, working with organizations that understand the ins and outs of the phase of your trial is key […]
In clinical research, working with organizations that understand the ins and outs of the phase of your trial is key […]
The processes necessary to support regulatory compliance require valuable time and resources within a clinical research institution. Regulatory tasks in particular require frequent
Elevating our consulting capabilities to accelerate clinical research and bring therapies to market sooner. YourEncore, a leading provider of drug
It’s safe to say 2020 has been more unpredictable than anyone could imagine. Through these unprecedented times, we have worked to provide the
On-demand eLearning maximizes ROI by cutting classroom costs and offering accessible, effective training that aligns with modern clinical research needs.
Community-based participatory research (CBPR) continues to come up in conversations surrounding diversity and inclusion in clinical research. This specialized method
The data gathered in a clinical trial is often collected by many different people, including investigators and coordinators, and interpreted
In our latest webinar, a panel of experts from research organizations, Community Health Centers (CHCs) and healthcare tech discussed racial
As part of FDA’s response to combat COVID-19, FDA convened its Vaccines and Related Biological Products Advisory Committee (VRBPAC). The
While many clinical trials are initiated by industry sponsors, such as pharmaceutical companies or contract research organizations (CROs), other trials
Project management is a key part of every successful business, and the clinical research industry is no exception. Research organizations regularly encounter multi-tiered projects, such as system implementations and integrations. In essence, every clinical trial is a complex project that requires adequate planning and leadership to be successful.
In Advarra’s recent virtual symposium, experts from industry and academia met to discuss how oncology research has influenced agility in clinical trial design, particularly during the COVID-19 pandemic. Panelists talked about how the COVID-19 pandemic has impacted oncology research and propelled the field’s groundbreaking contributions to research. They also explored ways the pandemic response has shaped the future of oncology research—and research in general.